- Home
- ADAG vs NA Comparison
ADAG vs NA Comparison
Compare ADAG & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- NA
- Stock Information
- Founded
- ADAG 2011
- NA 2019
- Country
- ADAG China
- NA China
- Employees
- ADAG N/A
- NA N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- NA Semiconductors
- Sector
- ADAG Health Care
- NA Technology
- Exchange
- ADAG Nasdaq
- NA Nasdaq
- Market Cap
- ADAG 110.8M
- NA 95.7M
- IPO Year
- ADAG 2021
- NA 2022
- Fundamental
- Price
- ADAG $2.24
- NA $5.00
- Analyst Decision
- ADAG Strong Buy
- NA
- Analyst Count
- ADAG 2
- NA 0
- Target Price
- ADAG $7.00
- NA N/A
- AVG Volume (30 Days)
- ADAG 140.2K
- NA 395.8K
- Earning Date
- ADAG 08-12-2025
- NA 08-15-2025
- Dividend Yield
- ADAG N/A
- NA N/A
- EPS Growth
- ADAG N/A
- NA N/A
- EPS
- ADAG N/A
- NA N/A
- Revenue
- ADAG $103,204.00
- NA $3,369,693.00
- Revenue This Year
- ADAG $9,789.15
- NA N/A
- Revenue Next Year
- ADAG $29.92
- NA N/A
- P/E Ratio
- ADAG N/A
- NA N/A
- Revenue Growth
- ADAG N/A
- NA N/A
- 52 Week Low
- ADAG $1.33
- NA $2.77
- 52 Week High
- ADAG $3.58
- NA $31.48
- Technical
- Relative Strength Index (RSI)
- ADAG 52.00
- NA 45.60
- Support Level
- ADAG $2.24
- NA $4.77
- Resistance Level
- ADAG $2.49
- NA $5.50
- Average True Range (ATR)
- ADAG 0.22
- NA 0.51
- MACD
- ADAG 0.00
- NA 0.07
- Stochastic Oscillator
- ADAG 14.81
- NA 15.03
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.